113 results
Page 3 of 6
8-K
EX-10.3
pfl83ea
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTACĀ® Protein
7:30am
8-K
EX-10.1
1m584lifmypy8 96k
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTACĀ® Protein
7:30am
8-K
rcoupi 77q7wywrp
9 Jun 21
Submission of Matters to a Vote of Security Holders
4:01pm
DEFA14A
fw9hw
26 Apr 21
Additional proxy soliciting materials
4:22pm
S-8
kvd9w m6l9
1 Mar 21
Registration of securities for employees
12:00am
S-8
EX-23.2
g7agzr4 w2qsm4
1 Mar 21
Registration of securities for employees
12:00am
8-K
EX-1.1
wq7r2u5bethhum94
18 Dec 20
Arvinas, Inc. Announces Pricing of $400 Million Public Offering of Common Stock
6:30am
424B5
9o26bp e3uq5dt
16 Dec 20
Prospectus supplement for primary offering
4:01pm
424B5
yk65ekalw4zkt 0qjj
14 Dec 20
Prospectus supplement for primary offering
4:48pm
S-3ASR
EX-4.5
vq7kvzk2gao87mcw0 hk
14 Dec 20
Automatic shelf registration
4:02pm
S-3ASR
EX-23.1
pon832abz3iii6
14 Dec 20
Automatic shelf registration
4:02pm
S-3ASR
u4um0 ueohwr
14 Dec 20
Automatic shelf registration
4:02pm
S-3ASR
EX-4.6
kwznri13
14 Dec 20
Automatic shelf registration
4:02pm
8-K
EX-99.1
5ik1xgs6oi9vq4el2
14 Dec 20
Regulation FD Disclosure
7:30am
8-K
EX-99.2
x7tlx9zb8d1lf5m
14 Dec 20
Regulation FD Disclosure
7:30am